NurExone Biologic Inc. (TSXV:NRX)

Canada flag Canada · Delayed Price · Currency is CAD
0.7400
+0.0500 (7.25%)
Aug 11, 2025, 4:00 PM EDT
7.25%
Market Cap60.01M
Revenue (ttm)n/a
Net Income (ttm)-8.34M
Shares Out80.01M
EPS (ttm)-0.12
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume87,442
Average Volume31,549
Open0.7200
Previous Close0.6900
Day's Range0.7000 - 0.7500
52-Week Range0.5200 - 0.8300
Beta-0.03
RSI60.15
Earnings DateAug 26, 2025

About Chuy's Holdings

NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It develops and commercializes the ExoTherapy platform for production of exosome-loaded nanodrugs. The company is also developing an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis caused by spinal cord injury using membrane-bound extracellular vesicles technology, as well as to treat traumatic brain injuries and other ne... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2020
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol NRX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.